Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Intrinsic Value
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is a CN-based company operating in Pharmaceuticals industry. [ Read More ]
The intrinsic value of one
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
stock under the Base Case scenario is
30.82
CNY.
Compared to the current market price of 31.55 CNY,
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
is
Overvalued by 2%.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's market capitalization is 51.3B CNY.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock price is 31.55 CNY.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock (30.82 CNY) is 2% less than its price (31.55 CNY).
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock (16.15 CNY) is 49% less than its price (31.55 CNY). Open DCF Valuation
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock price (31.55 CNY) is 31% less than its Relative Value (45.49 CNY). Open Relative Valuation
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has upside potential of 2% compared to the average analyst price target.
Open Wall St Estimates
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 13% to 12%.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 9%.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 10% to 9%.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 12%.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has positive three-year average ROIC (Return on Invested Capital): 11%. The company is efficient at using invested capital to generate operating income.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue has grown by 7% over the past 12 months.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue is forecast to grow at a rate of 4% per year over the next 3 years.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Altman Z-Score is equal to 2.38.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has positive three-year average ROE (Return on Equity): 13%. The company is efficient at transforming stockholders' equity into net income.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue has been growing by 7% per year for the last 3 years.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has positive Operating Income for the last twelve months.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has positive Gross Profit for the last twelve months.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has positive Net Income for the last twelve months.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has positive Free Cash Flow for the last twelve months.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's short-term assets (56B CNY) exceed its short-term liabilties (36B CNY).
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (21B CNY) than debt (16B CNY).
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's long-term assets (79B CNY) exceed its long-term liabilties (44B CNY).
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.45.
Valuation Backtest
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Run backtest to discover the historical profit from buying and selling
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Balance Sheet Decomposition
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
| Current Assets | 56B |
| Cash & Short-Term Investments | 20.6B |
| Receivables | 21.5B |
| Other Current Assets | 13.9B |
| Non-Current Assets | 22.6B |
| Long-Term Investments | 9.6B |
| PP&E | 7.5B |
| Intangibles | 4B |
| Other Non-Current Assets | 1.4B |
| Current Liabilities | 36.2B |
| Accounts Payable | 11.8B |
| Accrued Liabilities | 2.8B |
| Short-Term Debt | 11.7B |
| Other Current Liabilities | 10B |
| Non-Current Liabilities | 7.4B |
| Long-Term Debt | 3.9B |
| Other Non-Current Liabilities | 3.5B |
Earnings Waterfall
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
|
Revenue
|
75.5B
CNY
|
|
Cost of Revenue
|
-61.3B
CNY
|
|
Gross Profit
|
14.2B
CNY
|
|
Operating Expenses
|
-9.5B
CNY
|
|
Operating Income
|
4.7B
CNY
|
|
Other Expenses
|
-656m
CNY
|
|
Net Income
|
4.1B
CNY
|
Free Cash Flow Analysis
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
is 32.31 CNY
with a low forecast of 23.23 CNY and a high forecast of 44.1 CNY.
Shareholder Return
Price
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
| Average Annual Return | -5.03% |
| Standard Deviation of Annual Returns | 16.78% |
| Max Drawdown | -40% |
| Market Capitalization | 51.3B CNY |
| Shares Outstanding | 1 608 419 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Guangzhou, Guangdong and currently employs 25,437 full-time employees. The company went IPO on 2001-02-06. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd i is engaged in the pharmaceutical and healthcare industry. The firm's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The firm's Great South TCM includes research, development, manufacturing and sales for Chinese and western medicine, chemical raw medicine, natural drug, biological medicine and intermediates of chemical raw medicine. The firm's Great Health segment includes the research, development, manufacturing and sales of beverages, foods, health products and other products. The firm's Great Commerce segment includes wholesale, retail, import and export for western medicine, Chinese medicine and medical apparatus and instruments. The Great Medical segment is engaged in medical services, traditional Chinese medicine health preservation, modern pension and medical equipment industry.
Contact
IPO
Employees
Officers
The intrinsic value of one
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
stock under the Base Case scenario is
30.82
CNY.
Compared to the current market price of 31.55 CNY,
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
is
Overvalued by 2%.
You don't have any saved screeners yet
